1 Almirall. 85% of people unaware of actinic keratosis, the most common pre-cancerous skin condition. Available at: https://www.almirall.com/newsroom/news/85-of-people-unaware-of-actinic-keratosis-the-most-common-pre-cancerous-skin-condition. 2 Skin Cancer Foundation. Actinic Keratosis Overview. Available at: https://www.skincancer.org/skin-cancer-information/actinic-keratosis/#:/home/webapps/asp_fr/data/asp/publications/dragons-group/almirall_ar2023_en_k/demo-almirall-01:text=Actinic%20keratosis%20(AK)%20is%20the,to%20ultraviolet%20(UV)%20radiation. Read more Read more Read more Read more Read more Read more Read more Read more Read more Advancing medical dermatology Throughout 2023, our engagement at international dermatology congresses facilitated the presentation of our scientific work, learning from peers, and networking with healthcare professionals and pharmaceutical colleagues. Awareness campaigns At Almirall, we pursue our purpose of transforming patients' lives with a holistic approach to treating skin diseases. We go beyond treating physical symptoms, working to deeply understand the impact of skin diseases on the emotional health and wellbeing of patients and their families. Engagement with patient advocacy groups In 2023, our commitment to patient advocacy further intensified as we engaged in additional strategic partnerships with prominent organizations. Our alliance with the International Federation of Psoriatic Associations (IFPA) supported their efforts in advancing the global psoriasis community, which connects over 60 million people affected by the disease. Awareness campaigns At Almirall, we pursue our purpose of transforming patients' lives with a holistic approach to treating skin diseases. We go beyond treating physical symptoms, working to deeply understand the impact of skin diseases on the emotional health and wellbeing of patients and their families. One part of our mission is to raise awareness about skin diseases through engaging, relevant, and impactful methods for those affected. In 2023, we created a number of initiatives to improve disease awareness in the general public, including: Atopic dermatitis On September 14th, World Atopic Eczema Day, we initiated the "MovingAheAD" campaign. We launched the interactive Atopic Museum, a virtual space debunking myths about atopic dermatitis in an accessible and engaging way. Additionally, we conducted a social media campaign with local influencers across Europe. Psoriasis In May 2023, we launched our campaign "Nina," a groundbreaking series backed by the IFPA, our trusted partner dedicated to educating about the severe impact of psoriasis on patients' wellbeing. The series was widely shared in various European countries, complemented by a social media campaign with local influencers. In October, we continued our support of IFPA's World Psoriasis Day, which was themed "Access for All," advocating for tailored treatments for patients. Actinic keratosis Recognizing the second annual Global AK Day on May 24th, we created an online awareness campaign with support from the leading skin cancer awareness group, Euromelanoma. The campaign aimed to raise awareness of actinic keratosis, urging individuals with extensive UV exposure to recognize AK lesions as early warning signs. A survey launched during the campaign by Almirall highlighted the limited awareness of actinic keratosis in the general public. It demonstrated that 85% of people are unaware of AK,1 despite it being the most common pre-cancerous skin condition.2 Advancing medical dermatology Throughout 2023, our engagement at international dermatology congresses facilitated the presentation of our scientific work, learning from peers, and networking with healthcare professionals and pharmaceutical colleagues. We presented 145 publications at important events like the European Academy of Dermatology and Venereology (EADV), the World Congress of Dermatology (WCD), Fall Clinical, the Revolutionizing Atopic Dermatitis (RAD) Conference and the European Association of Dermato-Oncology (EADO). Highlights include: EADV, Fall Clinical, WCD, RAD We presented key findings from lebrikizumab phase III pivotal studies (ADvantage, ADvocate 1 & 2, ADjoin, ADhere). EADV & WCD We highlighted the results of the ground-breaking POSITIVE study, which assesses the wellbeing of people suffering from moderate-to-severe psoriasis treated with tildrakizumab. One of our key activities to help advance the knowledge of skin biology and skin diseases is to host our own annual global dermatology meetings. At these events that attract a high number of leading dermatologists and other experts, we provide a platform to highlight scientific and dermatological topics of interest, advances in science and innovation, and a forum for scientific exchange. Notable moments from 2023 include: Skin Academy The 14th edition of Almirall's flagship education forum, the Skin Academy, was held in Barcelona under the leadership of Prof. Diamant Thaçi and Dr. Susana Puig. It brought together more than 500 physicians from 15 countries. With the theme "Applying the latest insights in dermatology to clinical practice," Prof. Mark Lebhowl inaugurated the event, sharing invaluable insights from his distinguished career. A total of 16 lectures and 3 panels helped experts connect and exchange their knowledge. Immunoskin Since 2022, our medical meeting targeting immune-mediated skin conditions has attracted dermatology experts from across Europe. The second edition saw over 200 dermatologists engage in a comprehensive 2-day training programme chaired by Dr. Andreas Pinter and a panel of 14 high-level speakers, covering conditions like psoriasis, atopic dermatitis, vitiligo, and hidradenitis suppurativa. Engagement with patient advocacy groups In 2023, our commitment to patient advocacy further intensified as we engaged in additional strategic partnerships with prominent organizations. Our alliance with the International Federation of Psoriatic Associations (IFPA) supported their efforts in advancing the global psoriasis community, which connects over 60 million people affected by the disease. We also supported GlobalSkin, a global alliance connecting over 235 dermatology patient organizations, in their efforts to advocate for patient-centric healthcare. Our engagement, notably at the GlobalSkin Conference 2023, supported the Atopic Eczema Community by helping to amplify their voices. Additionally, we sponsored EUROPSO's innovative PSO Podcasts, an initiative that sheds light on the psycho-social effects of psoriasis while further educating on the significance of wellbeing for patients and their families. Germany In Germany, we supported the educational and awareness campaigns of patient organizations representing people with chronic skin and au-toimmune diseases or allergies. We collaborat-ed with Deutscher Neurodermitis Bund e.V. (DNB) to disseminate educational information to patients and Deutscher Allergie- und Asth-mabund (DAAB) to co-create a patient bro-chure. We also supported the patient organiza-tion Netzwerk Autoimmunerkrankter (NIK e.V.) along with Derma2go, the leading expert in digital dermatology, with their campaign "Skin Week," which is dedicated to psoriasis and at-opic dermatitis. Spain Since 2019, we have collaborated with the patient association Acción Psoriasis on the ''Healthy Habits Project''. This initiative aims to understand the habits of people living with psoriasis, focusing on diet, physical activity, and emotional wellbeing, to address the need for guidance and support. After having launched surveys on dietary habits and mental health, in 2023 we launched a survey on physical exercise to help provide patients with tailored solutions that meet their needs, and ultimately improve their quality of life. For Multiple Sclerosis (MS), we partnered with regional MS patient associations to run solidarity campaigns, providing support and visibility to more than 9,000 MS families. We also participated in regional campaigns for World and National Multiple Sclerosis Day, conducted workshops to teach patients how to manage their symptoms over time, and launched the initiative "Cuéntalo" with the FEM (Multiple Sclerosis Federation) to give voice and empowerment to MS patients. On World Atopic Dermatitis Day, we partnered with AADA (Asociación de Afectados por la Dermatitis Atópica), providing them support on a disease awareness video and integrating the association into an internal awareness and CSR initiative, "YouFeelWell." Italy Almirall supports the DERMA-POINT portal, which is designed to inform, educate and support patients in managing and understanding PSO, AD, and AK. The portal also runs digital awareness campaigns and offers free skin screening programmes with APIAFCO (Associazione Psoriasici Italiani Amici della Fondazione Corazza) serving as its patron. Additionally, we provided support to l'ADIPSO (Associazione per la Difesa degli Psoriasici) to organize a virtual World Psoriasis Day. United Kingdom As part of National Eczema Week, we supported the patient organization National Eczema Society (NES) to produce podcasts for patients. These vividly conveyed the impact of atopic dermatitis (AD) on people’s lives and helped listeners to understand the condition from a patient's perspective through sharing real-life experiences. Another initiative developed with the NES is the "Patient Forum," designed to embrace diverse patient experiences. It aims to amplify patient perspectives, address emotional challenges and wellbeing concerns, and ensure a holistic approach to their atopic dermatitis journey. Denmark Almirall provided support to the patient organization Atopisk Eksem Forening, which aims to raise awareness and shorten the time for dermatological treatment referrals. This included a meeting organized in the Danish national parliament. Almirall also provided financial support to raise awareness about AD by targeting patients, health professionals, and parents, utilizing Prof. Agner's new book on atopic dermatitis. Sweden and Norway Almirall conducted surveys in partnership with Psoriasisförbundet, the psoriasis patient organi-zation in Sweden, and Psoriasis og Eksem Forbun-det, the Norwegian patient organization for psori-asis and atopic dermatitis, which concentrate on patients' quality of life, wellbeing and treatment satisfaction. Their objective is to gather wellbe-ing data from Swedish and Norwegian psoriasis patients, in order to heighten awareness about the importance of wellbeing among patients, dermatologists, and within the political commu-nity. Additionally, Almirall supported a conference organized by the Swedish regional patient or-ganization, Psoriasisforeningen Halland. The conference sought to spotlight the challenges and unmet needs of psoriatic patients and to engage regional politicians in discussions about the future of patient care. France In France, we support a range of patient associations. In 2023, we collaborated with the France Psoriasis Association on World Psoriasis Day by organizing a round table with healthcare professionals, as well as representatives of the patient association. These activities emphasized the significance of psychological factors in the wellbeing of patients. We also supported the French Eczema Association, which fights for better knowledge of atopic dermatitis, by conducting patient surveys on care trajectories and the quality of care perception in France in regard to this disease. Lastly, we endorsed a patient and digital health event, providing a platform to over twenty speakers engaging with industrial and academ-ic institutions, healthcare professionals, ministe-rial delegates, and patient associations, to fos-ter discussions regarding the potential of digital tools to enhance dermatology. The Netherlands We sponsored the National Eczema Institutional Project (NCEP), which brings together all stakeholders within atopic dermatitis care. The goal was to provide information, training and tools for both patients and healthcare professionals, making resources readily accessible, widely disseminated, and effectively implemented. This successful approach was built on the close collaboration with patient associations and all stakeholders involved in the direct or indirect provision of care. As a result, the project delivered information and support tools that could be used nationwide, in line with Almirall´s commitment to support patient access to education, care, and HCPs. The United States In the United States, we partnered with The Skin Cancer Foundation, an organization dedicated to equipping individuals with resources for skin cancer prevention, detection, and treatment. For the second consecutive year, we contributed to them through our "YouFeelWell" wellness challenge.